Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flurry of Russian Medtech Regulatory System Proposals Keeps Manufacturers On Their Toes

Executive Summary

Russian medtech industry expert Alexey Stepanov reports an uptick in regulatory activity nationally in the final trimester of 2016. The catalyst seems to be the impending launch of the system of harmonization of medical device regulation within the regional Eurasian Economic Union (EAEU).

You may also be interested in...



Russia Adds Medtech Regulatory Resources, Clarifies Tech Files & Instructions-For-Use Needs

Russia's medtech regulatory agency Roszdravnadzor has received its share of criticism, but its performance has improved of late. New health ministry rules on technical file requirements have given the medtech industry additional cause for optimism.

Russian Icebreaker: IMEDA Seeks To Keep Medtech Channels Open

Addressing pricing challenges for implantable devices, responding to a national localization drive and working with the Russian health-care products regulator Roszdravnadzor on market access issues for international companies are high priorities for IMEDA, Russia's International Medical Device Manufacturers Association. But, increasingly, another major focus is ensuring the stability of the local industry.

Russian Medtech Industry Wants Quicker Progress On Eurasian Bloc Plans – 2017 Now Targeted

The much-anticipated Eurasian Economic Union (EAEU) was originally targeted to come into effect at the start of 2016, but more than year later, the five-member trading bloc has yet to be ratified by all nations. The Russian medtech industry is impatient for progress, but IMEDA's Sergey Kolosov sees some promising signs in recent developments.

Related Content

Topics

UsernamePublicRestriction

Register

MT104131

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel